Ecliptasaponin A
CAS: 78285-90-2
Ref. 3D-FE74256
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
- (3beta,16alpha)-3-(beta-D-Glucopyranosyloxy)-16-hydroxyolean-12-en-28-oic acid
- (3β,16α)-3-(β-<span class="text-smallcaps">D</span>-Glucopyranosyloxy)-16-hydroxyolean-12-en-28-oic acid
- Echinocystic acid-3-O-glucoside
- Eclalbasaponin II
- Olean-12-en-28-oic acid, 3-(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-16-hydroxy-, (3β,16α)-
Ecliptasaponin A is a growth factor-β1 analogue that inhibits TNF-α and interleukin-6 production in macrophages by modulating the mitochondrial membrane potential. It also has an anti-cancer effect. Ecliptasaponin A is a glycoside with one hydroxyl group and one dinucleotide phosphate, which are characteristic features of saponins. The autophagic process is activated by Ecliptasaponin A, which may be due to its ability to increase the levels of endogenous substances such as lysosomal acid phosphatase. Ecliptasaponin A has been shown to have a protective effect on the lacrimal gland, which may be due to its ability to stimulate the secretion of endogenous substances such as lacrimal gland fluid.
Chemical properties
Technical inquiry about: 3D-FE74256 Ecliptasaponin A
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
